Home › Stargardt Disease › Oregon
Stargardt Disease clinical trials in Oregon
4 studies for Stargardt Disease are looking for participants at sites in Oregon.
Cities in Oregon
A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
- Casey Eye Institute - Oregon Health & Science University, Portland
RecruitingObservational study
Ages 6 and older · All sexes · Updated Aug 25, 2026 · NCT07425574Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
- Casey Eye Institute OHSU, Portland
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Dec 2, 2025 · NCT06467344An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene
- Oregon Health & Science University, Portland
RecruitingObservational study
Ages 12 to 65 · All sexes · Updated Sep 19, 2025 · NCT06435000A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)
- Oregon Health & Science University, Portland
RecruitingPhase 1/2
Ages 12 to 65 · All sexes · Updated Apr 29, 2025 · NCT06942572From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.